Log in
Request a free trial
Request a free trial
Log in
Products
Solutions
Data
News & Analysis
About
Blog
News & Analysis
driven by the PitchBook Platform
Articles
reports
All articles
All
Venture Capital
Private Equity
M&A
Tech
Europe
reports
Subscribe
AGTC Lands $37.5M Series B
November 21, 2012
Share:
Applied Genetic Technologies
, a Gainesville, Fla.-based biotech company, has closed on $37.5 million in Series B funding. According to the company’s website, it seeks to “identify diseases which can be treated by delivery of a known gene and for which no other adequate treatments are available.” The round was led by
Alta Partners
and
S.R. One
, with participation from
Osage University Partners
,
InterWest
,
Intersouth Partners
and
MedImmune Ventures
.
Applied Genetic Technologies
Drug Discovery
Alachua, FL
$37.5 million
Series B
View details
Investors
Alta Partners
(lead)
S.R. One
(lead)
InterWest Partners
Intersouth Partners
MedImmune Ventures
Osage Partners
Share:
Tags:
Private Equity,
Venture Capital
Related content
Load more
